InvestSMART

Dorsavi Ltd (ASX: DVL) - Announcements

- Current share price for DVL : $0.021

ASX company news and announcements for Dorsavi Ltd (DVL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Dorsavi Ltd (DVL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Dorsavi Ltd (DVL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Dorsavi Ltd (DVL)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$26 Application for quotation of securities - DVL 14 Aug 2024 8:51AM $0.011 $0.021 risen by 90.91%
$26 Application for quotation of securities - DVL 14 Aug 2024 8:49AM $0.011 $0.021 risen by 90.91%
$26 Notification regarding unquoted securities - DVL 14 Aug 2024 8:49AM $0.011 $0.021 risen by 90.91%
$26 Notification regarding unquoted securities - DVL 14 Aug 2024 8:47AM $0.011 $0.021 risen by 90.91%
$26 Application for quotation of securities - DVL 14 Aug 2024 8:42AM $0.011 $0.021 risen by 90.91%
$26 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jul 2024 8:30AM $0.012 $0.021 risen by 75%
$26 dorsaVi secures A$110k in new contracts 29 Jul 2024 8:29AM $0.012 $0.021 risen by 75%
$26 Proposed issue of securities - DVL 24 Jul 2024 9:24AM $0.013 $0.021 risen by 61.54%
$26 Proposed issue of securities - DVL 24 Jul 2024 9:24AM $0.013 $0.021 risen by 61.54%
$26 dorsaVi secures commitments for $1.1m placement 24 Jul 2024 9:23AM $0.013 $0.021 risen by 61.54%
$26 Trading Halt 22 Jul 2024 8:37AM $0.013 $0.021 risen by 61.54%
$26 dorsaVi completes clinical study with Norton Healthcare 15 Jul 2024 9:06AM $0.012 $0.021 risen by 75%
$26 Change of Director's Interest Notice 14 Jun 2024 4:57PM $0.011 $0.021 risen by 90.91%
$26 Section 708A Cleansing Notice 13 Jun 2024 5:13PM $0.012 $0.021 risen by 75%
$26 Notification regarding unquoted securities - DVL 13 Jun 2024 5:06PM $0.012 $0.021 risen by 75%
$26 Application for quotation of securities - DVL 13 Jun 2024 5:03PM $0.012 $0.021 risen by 75%
$26 Notification regarding unquoted securities - DVL 13 Jun 2024 5:00PM $0.012 $0.021 risen by 75%
$26 Application for quotation of securities - DVL 13 Jun 2024 4:59PM $0.012 $0.021 risen by 75%
$26 Notification of cessation of securities - DVL 13 Jun 2024 4:54PM $0.012 $0.021 risen by 75%
$26 Application for quotation of securities - DVL 13 Jun 2024 4:52PM $0.012 $0.021 risen by 75%
$26 Application for quotation of securities - DVL 13 Jun 2024 4:48PM $0.012 $0.021 risen by 75%
$26 Application for quotation of securities - DVL 13 Jun 2024 4:42PM $0.012 $0.021 risen by 75%
$26 Results of Meeting 27 May 2024 12:17PM $0.013 $0.021 risen by 61.54%
$26 DorsaVi AI NMA achieves gold-standard validation 21 May 2024 8:33AM $0.014 $0.021 risen by 50%
$26 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2024 9:20AM $0.013 $0.021 risen by 61.54%

176 - 200 of 762 results

Page 8 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.